3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Small Cell Lung Carcinoma
1
Sleep Wake Disorders
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Obesity
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Malignant Primary Pelvic Neoplasm
1
Lymphoma, Non-Hodgkin
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Inflammatory Breast Neoplasms
1
Hodgkin Disease
1
Hematopoietic and Lymphatic System Neoplasm
1
Hematologic Neoplasms
1
Heart Defects, Congenital
1
Fatigue
1
Depression
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8
1
Carcinoma, Merkel Cell
1
Anxiety Disorders
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
pembrolizumab
38
Bevacizumab
23
Cyclophosphamide
22
Standard of Care
18
Blood Specimen Collection
17
Carboplatin
16
Paclitaxel
15
Nivolumab
14
Gemcitabine
14
Pemetrexed
13
Exercise
13
Cisplatin
12
atezolizumab
11
Radiotherapy
11
Fluorouracil
11
Doxorubicin
11
Surveys and Questionnaires
9
Rituximab
9
Oxaliplatin
9
Magnetic Resonance Spectroscopy
9
Leucovorin
9
Cetuximab
9
Biopsy
9
130-nm albumin-bound paclitaxel
9
durvalumab
8
abemaciclib
8
Docetaxel
8
olaparib
7
Temozolomide
7
Prednisone
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms
×
Exercise Test
×
90 days
×
Clear all
No trials found.